Not for distribution to U.S. Newswire Services or for dissemination in the United States.
INDIVA Congratulates Master Grower on the Listing of his Memoir on Amazon and Indigo
LONDON, ON – Wednesday, September 26, 2018: INDIVA Limited (the “Company” or “INDIVA“) (TSX-V:NDVA) congratulates Pete Young on the Amazon and Indigo listing of his soon to be released memoir, The High Road: a Pot Grower’s Journey from the Black Market to the Stock Market. The High Road tells the story of Pete’s activism and efforts to legalize cannabis in Canada and compassionate supply of cannabis to medical clients through the London Compassion Society, a not-for-profit he founded.
“Pete worked very hard on this project. The book’s listing on Amazon and Indigo is validation for his good work.” explained Niel Marotta, the Company’s CEO. “We couldn’t be more proud of Pete.”
The High Road is being published and will be available for purchase on October 17, 2018, which corresponds with the legalization of cannabis in Canada.
Niel Marotta, CEO, INDIVA
Email: [email protected]
Steve Low, Investor Relations
Email: [email protected]
INDIVA’s wholly owned subsidiary is a Licensed Producer under Canada’s Access to Cannabis for Medical Purposes Regulation (“ACMPR“).
INDIVA’s mission is to offer cannabis products that have a positive impact, improving lives and communities.
DISCLAIMER & READER ADVISORY
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the information contained herein and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.
Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties’ current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to future expansion of INDIVA’s facility and anticipated activities to be carried out at such facility, future product offerings and applicable regulatory approvals related thereto, future entry into additional markets, changes to laws and regulations in Canada generally, and specifically with respect to edible cannabis products, and compliance with applicable regulations, including those of the TSX Venture Exchange. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include INDIVA being able to obtain necessary regulatory and other third parties approvals, completion of the expansion of the INDIVA facility, and licensing and other risks associated with regulated ACMPR entities. The forward looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.
This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.